Abstract:Malocclusions are common craniofacial malformations which cause quality of life and health problems if left untreated. Unfortunately, the current treatment for severe skeletal malocclusion is invasive surgery. Developing improved therapeutic options requires a deeper understanding of the cellular mechanisms responsible for determining jaw bone length. We have recently shown that neural crest mesenchyme (NCM) can alter jaw length by controlling recruitment and function of mesoderm-derived osteoclasts. Transforming growth factor beta (TGF-β) signaling is critical to craniofacial development by directing bone resorption and formation, and heterozygous mutations in TGF-β type I receptor (TGFBR1) are associated with micrognathia in humans. To identify what role TGF-β signaling in NCM plays in controlling osteoclasts during mandibular development, mandibles of mouse embryos deficient in the gene encoding Tgfbr1 specifically in NCM were analyzed. Our lab and others have demonstrated that Tgfbr1fl/fl;Wnt1-Cre mice display significantly shorter mandibles with no condylar, coronoid, or angular processes. We hypothesize that TGF-β signaling in NCM can also direct later bone remodeling and further regulate late embryonic jaw bone length. Interestingly, analysis of mandibular bone through micro-computed tomography and Masson's trichrome revealed no significant difference in bone quality between the Tgfbr1fl/fl;Wnt1-Cre mice and controls, as measured by bone perimeter/bone area, trabecular rod-like diameter, number and separation, and gene expression of Collagen type 1 alpha 1 (Col1α1) and Matrix metalloproteinase 13 (Mmp13). Though there was not a difference in localization of bone resorption within the mandible indicated by TRAP staining, Tgfbr1fl/fl;Wnt1-Cre mice had approximately three-fold less osteoclast number and perimeter than controls. Gene expression of receptor activator of nuclear factor kappa-B (Rank) and Mmp9, markers of osteoclasts and their activity, also showed a three-fold decrease in Tgfbr1fl/fl;Wnt1-Cre mandibles. Evaluation of osteoblast-to-osteoclast signaling revealed no significant difference between Tgfbr1fl/fl;Wnt1-Cre mandibles and controls, leaving the specific mechanism unresolved. Finally, pharmacological inhibition of Tgfbr1 signaling during the initiation of bone mineralization and resorption significantly shortened jaw length in embryos. We conclude that TGF-β signaling in NCM decreases mesoderm-derived osteoclast number, that TGF-β signaling in NCM impacts jaw length late in development, and that this osteoblast-to-osteoclast communication may be occurring through an undescribed mechanism.

Genetic Determination of the Cellular Basis of the Ghrelin-Dependent Bone Remodeling

Ghrelineffects on the growth hormone release, osteoblast proliferation and bone growth

Effects of ghrelin on the proliferation and differentiation of human osteoblasts

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

Neural regulation of bone remodeling: Identifying novel neural molecules and pathways between brain and bone

Notch Signaling Maintains Bone Marrow Mesenchymal Progenitors by Suppressing Osteoblast Differentiation

The progress of relationships between ghrelin and osteoporosis

Ghrelin Attenuates The Osteoblastic Differentiation Of Vascular Smooth Muscle Cells Through The Erk Pathway

Role and molecular mechanism of ghrelin in degenerative musculoskeletal disorders

Regulation of Body Length and Bone Mass by Gpr126/Adgrg6

Dysregulation of the ghrelin/RANKL/OPG pathway in bone mass is related to AIS osteopenia

Osteoblastic Molecular Scaffold Gab1 Is Required For Maintaining Bone Homeostasis

Ghrelin Inhibits the Apoptosis of MC3T3-E1 Cells Through ERK and AKT Signaling Pathway.

GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells

Local versus systemic control of bone and skeletal muscle mass by components of the transforming growth factor-β signaling pathway

Serum Response Factor Regulates Bone Formation Via Igf-1 and Runx2 Signals

Ablation of Gsα Signaling in Osteoclast Progenitor Cells Adversely Affects Skeletal Bone Maintenance.

Gs Alpha Controls Cortical Bone Quality By Regulating Osteoclast Differentiation Via Camp/Pka And Beta-Catenin Pathways

HBP/O-GlcNAcylation Metabolic Axis Regulates Bone Resorption Outcome

Gsα Controls Cortical Bone Quality by Regulating Osteoclast Differentiation via cAMP/PKA and β-Catenin Pathways

TGF-β Signaling in Cranial Neural Crest Affects Late-Stage Mandibular Bone Resorption and Length